Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial.

Journal

Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043

Informations de publication

Date de publication:
2020
Historique:
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 2 2 2021
Statut: epublish

Résumé

[This retracts the article DOI: 10.1186/2045-7022-5-S3-P30.].

Identifiants

DOI: 10.1186/s13601-020-00356-5 PMID: 33524077 PMC: PMC7653747
pubmed: 33524077
doi: 10.1186/s13601-020-00356-5
pii: 356
pmc: PMC7653747
doi:

Types de publication

Retraction of Publication

Langues

eng

Pagination

48

Informations de copyright

© The Author(s) 2020.

Auteurs

Robert Boyle (R)

Imperial College London, London, UK.

Nick Brown (N)

Salisbury Healthcare NHS Trust, Salisbury, UK.

Wen Chin Chiang (WC)

KK Women's and Children's Hospital, Singapore, Singapore.

Chua Mei Chien (CM)

KK Women's and Children's Hospital, Singapore, Singapore.

Michael Gold (M)

Women's and Children's Hospital, Adelaide, Australia.

Jonathan Hourihane (J)

University College, Cork, Ireland.

Jane Peake (J)

Royal Children's Hospital, Brisbane, Australia.

Patrick Quinn (P)

Women's and Children's Hospital, Adelaide, Australia.

Raj Rao (R)

Poole Hospital NHS Trust, Poole, UK.

Peter Smith (P)

Gold Coast Hospital, Gold Coast, Australia.

Mimi Tang (M)

Murdoch Children's Research Institute, Melbourne, Australia.

John Ziegler (J)

Sydney Children's Hospital, Sydney, Australia.

John Warner (J)

Imperial College London, London, UK.

Classifications MeSH